ENB Therapeutics Announces Successful Completion of the First Dosing Cohort in Phase I Clinical Trial of ENB-003 in Combination with Pembrolizumab
ENB-003 is the Company’s first in class small molecule therapeutic selectively targeting the ETB receptor…
Africa’s First CoC Registry Goes Live for SA’s 20 September Trade Deadline
Santamarina + Steta Strengthens Its Tax Practice with the Addition of Luis Curiel Pina and Francisco Carbajal Dominguez
Berry AI and Culver’s Announce Brand-Wide Vision AI Deployment Across 1,000+ Restaurants
Sensiba Names Monic Ramirez as Managing Partner Amid Firm-Wide Transformation